Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-12

FDA Approved: IMODIUM A-D — Supplemental Application (Kenvue Brands LLC)

View source ↗

Summary

The FDA approved a supplemental application for IMODIUM A-D (loperamide hydrochloride) from Kenvue Brands LLC, resulting in labeling changes for this OTC anti-d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IMODIUM A-D (Loperamide hydrochloride)

Snippet

SUPPL AP for IMODIUM A-D (LOPERAMIDE HYDROCHLORIDE)